97. 潰瘍性大腸炎 [臨床試験数:2,269,薬物数:1,331(DrugBank:241),標的遺伝子数:114,標的パスウェイ数:181

Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03724175
(ClinicalTrials.gov)
August 26, 201912/10/2018The Role of Secondary Bile Acids in Intestinal InflammationThe Role of Secondary Bile Acids in Intestinal InflammationUlcerative Colitis;PouchitisDrug: ursodiol (ursodeoxycholic acid, UDCA)Stanford UniversityNULLRecruiting18 Years70 YearsAll15Phase 2/Phase 3United States
2ChiCTR2000038316
2018-08-012020-09-17Effect of ursodeoxycholic acid on ulcerative colitis and serumal IL-23, IL-17 and intestinal flora levelsEffect of ursodeoxycholic acid on ulcerative colitis and serumal IL-23, IL-17 and intestinal flora levels Ulcerative colitiscontrol group:Mesalazine alone;trial group:Mesalazine and ursodeoxycholic acid soft capsule;Patients with mild bile reflux gastritis: ursodeoxycholic acid soft capsule;Healthy control group:Nil;The 900th Hospital of PLANULLCompleted1875Bothcontrol group:20;trial group:20;Patients with mild bile reflux gastritis:20;Healthy control group:20;Phase 4China
3EUCTR2009-010921-38-NL
(EUCTR)
08/09/200902/03/2009Chemopreventive effects of 5-ASA and UDCA in Ulcerative Colitis:A Double-blind, Randomized Placebo-controlled Pilot Study - CRC chemoprevention in UCChemopreventive effects of 5-ASA and UDCA in Ulcerative Colitis:A Double-blind, Randomized Placebo-controlled Pilot Study - CRC chemoprevention in UC Ulcerative Colitis and the risk of developing colorectal cancer.
MedDRA version: 13.1;Level: PT;Classification code 10021972;Term: Inflammatory bowel disease;System Organ Class: 10017947 - Gastrointestinal disorders
Trade Name: Salofalk
INN or Proposed INN: mesalazine
Trade Name: Ursofalk
INN or Proposed INN: ursodeoxycholic acid
UMC UtrechtNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
Netherlands